UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035812
Receipt number R000040750
Scientific Title Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer
Date of disclosure of the study information 2019/02/08
Last modified on 2019/02/08 14:40:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

Acronym

Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

Scientific Title

Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

Scientific Title:Acronym

Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer

Region

Japan


Condition

Condition

non-small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This trial evaluated the efficacy and toxicity of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer (NSCLC).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Overall response rate

Key secondary outcomes

Progression-free survival
Overall survival
safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

S1 is administered orally twice daily for 14 days a day, according to the body surface area, followed by 7 days off. PTX 80 mg / m 2 is administered on Day 1, 8 by drip infusion. One cycle is 21 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) A case in which definitive diagnosis of non-small cell lung cancer was obtained by histology or cytology
2) Cases with measurable lesions
3) Patients with a history of chemotherapy treatment containing 1 platinum regimen over 1 regimen (treatment history of surgical therapy and radiotherapy is not limited)
4) Cases with 4 weeks or more have passed since the end of previous chemotherapy
5) Case of over 20 years old
6) Case of Performance Status 0-1 of ECOG
7) Cases with sufficient bone marrow function and organ function
8) Cases in which survival for more than 2 months can be expected
9) Cases with oral administration
10) Case informed consent obtained document from patient himself

Key exclusion criteria

1: Cases with serious complications
Interstitial pneumonia
Serious heart disease
diabetes which is difficult to control
Serious infectious diseases
2: Cases with other active organs and overlapping cancers
3: Patients with a history of severe hypersensitivity
4: Case in which flucytosine is being administered
5) Cases with a history of alcohol hypersensitivity

Target sample size

45


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshinobu Iwasaki

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Pulmonary Medicine

Zip code


Address

Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

TEL

075-251-5513

Email

c1981311@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yusuke Chihara

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Pulmonary Medicine

Zip code


Address

Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

TEL

075-251-5513

Homepage URL


Email

c1981311@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kyoto Prefectural University of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 11 Month 12 Day

Date of IRB


Anticipated trial start date

2011 Year 11 Month 12 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 08 Day

Last modified on

2019 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040750


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name